BRBernardo Ratilal

Bernardo Ratilal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bernardo Ratilal has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Cristina Sampaio

    Faculdade de Medicina de Lisboa; Laboratório de Farmacologia Clínica e Terapêutica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028

    6 shared publications
  • João Costa

    Faculdade de Medicina de Lisboa; Laboratório de Farmacologia Clínica e Terapêutica; Av. Prof. Egas Moniz Lisboa Portugal 1649-028

    6 shared publications
  • Lia Pappamikail

    Hospital de São José; Department of Neurosurgery; Rua José António Serrano Lisboa Portugal 1150-199

    3 shared publications
  • Cristina Sampaio

    CHDIFoundation New York New York USA

    2 shared publications
  • J Costa

    Department of Neurosurgery, Hospital de Sáo José, Rua José Antnié Serrano, Lisboa 1150‐199, PORTUGAL

    2 shared publications
  • Antonio L. Fernandes

    Department of Neuroradiology, Hospital Sao Jose, Lisboa, Portugal

    1 shared publication

Latest Publications

  • Open Access

    Spontaneous pseudomeningocele associated with lumbar spondylolisthesis: A case report and review of the literature

    by Gonçalo Novais, Bernardo Ratilal, Lia Pappamikail, Pedro Branco, Nuno Reis

    Pseudomeningocele, an extradural collection of cerebrospinal fluid (CSF), has only been rarely reported to occur spontaneously in conjunction with isthmic spondylolisthesis (with lysis) in the lumbar spine. A 68-year-old male presented with low back pain and neurogenic claudication of several years duration without any history of trauma, epidural spine injections, or spine surgery. Lumbosacral magnetic resonance imaging (MRI) revealed a grade-I L4-L5 isthmic spondylolisthesis with spinal canal narrowing and a posterior paravertebral collection consistent with CSF. The patient underwent a spinal decompression consisting of a complete L4 and partial L5 laminectomy, a bilateral L4-L5 instrumented fusion (due to the lysis defect), and closure of the CFS fistula. The histology analysis was compatible with a pseudomeningocele. Lumbar isthmic spondylolisthesis may lead to changes in the elastic properties of the underlying dura mater. Rarely, this may lead to meningeal tears and formation of a pseudomeningocele. Historically, one must always check for a prior epidural injection that could have resulted in this complication. Additionally, as most likely the case here, the lysis defect was responsible for the foraminal dural laceration resulting in the pseudomeningocele.


  • Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures

    by Bernardo O Ratilal, João Costa, Lia Pappamikail, Cristina Sampaio

    Basilar skull fractures predispose patients to meningitis because of the possible direct contact of bacteria in the paranasal sinuses, nasopharynx or middle ear with the central nervous system (CNS). Cerebrospinal fluid (CSF) leakage has been associated with a greater risk of contracting meningitis. Antibiotics are often given prophylactically, although their role in preventing bacterial meningitis has not been established. To evaluate the effectiveness of prophylactic antibiotics for preventing meningitis in patients with basilar skull fractures. We searched CENTRAL (2014, Issue 5), MEDLINE (1966 to June week 1, 2014), EMBASE (1974 to June 2014) and LILACS (1982 to June 2014). We also performed an electronic search of meeting proceedings from the American Association of Neurological Surgeons (1997 to September 2005) and handsearched the abstracts of meeting proceedings of the European Association of Neurosurgical Societies (1995, 1999 and 2003). Randomised controlled trials (RCTs) comparing any antibiotic versus placebo or no intervention. We also identified non-RCTs to perform a separate meta-analysis in order to compare results. Three review authors independently screened and selected trials, assessed risk of bias and extracted data. We sought clarification with trial authors when needed. We pooled risk ratios (RRs) for dichotomous data with their 95% confidence intervals (CIs) using a random-effects model. We assessed the overall quality of evidence using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. In this update we did not identify any new trials for inclusion. We included five RCTs with 208 participants in the review and meta-analysis. We also identified 17 non-RCTs comparing different types of antibiotic prophylaxis with placebo or no intervention in patients with basilar skull fractures. Most trials presented insufficient methodological detail. All studies included meningitis in their primary outcome. When we evaluated the five included RCTs, there were no significant differences between antibiotic prophylaxis groups and control groups in terms of reduction of the frequency of meningitis, all-cause mortality, meningitis-related mortality and need for surgical correction in patients with CSF leakage. There were no reported adverse effects of antibiotic administration, although one of the five RCTs reported an induced change in the posterior nasopharyngeal flora towards potentially more pathogenic organisms resistant to the antibiotic regimen used in prophylaxis. We performed a subgroup analysis to evaluate the primary outcome in patients with and without CSF leakage. We also completed a meta-analysis of all the identified controlled non-RCTs (enrolling a total of 2168 patients), which produced results consistent with the randomised data from the included studies.Using the GRADE approach, we assessed the quality of trials as moderate. Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with basilar skull fractures, whether there is evidence of CSF leakage or not. Until more research is available, the effectiveness of antibiotics in patients with basilar skull fractures cannot be determined because studies published to date are flawed by biases. Large, appropriately designed RCTs are needed.


  • Anticonvulsants for preventing seizures in patients with chronic subdural haematoma

    by Bernardo O Ratilal, Lia Pappamikail, João Costa, Cristina Sampaio

    Anticonvulsant therapy is sometimes used prophylactically in patients with chronic subdural haematoma, although the benefit is unclear. To assess the effects of prophylactic anticonvulsants in patients with chronic subdural haematoma, in both the pre- and post-operative periods. We searched the Cochrane Injuries Group's Specialised Register, CENTRAL (The Cochrane Library), MEDLINE (OvidSP), EMBASE (OvidSP), PubMed, LILACS, and the databases clinicaltrials.gov, the WHO International Clinical Trials Registry Platform, and Current Controlled Trials. The search was through 27th March 2013. Randomised controlled trials comparing any anticonvulsant versus placebo or no intervention. Three authors screened the search results to identify relevant studies. No studies met the inclusion criteria for the review. No randomised controlled trials were identified. No formal recommendations can be made about the use of prophylactic anticonvulsants in patients with chronic subdural haematoma based on the literature currently available. There are no randomised controlled trials on this topic, and non-controlled studies have conflicting results. There is an urgent need for well-designed randomised controlled trials.


  • Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures

    by Bernardo O Ratilal, João Costa, Cristina Sampaio, Lia Pappamikail

    Basilar skull fractures (BSF) predispose patients to meningitis because of the possible direct contact of bacteria in the paranasal sinuses, nasopharynx or middle ear with the central nervous system (CNS). Cerebrospinal fluid (CSF) leakage has been associated with a greater risk of contracting meningitis. Antibiotics are often given prophylactically, although their role in preventing bacterial meningitis is not established. To evaluate the effectiveness of prophylactic antibiotics for preventing meningitis in patients with BSF. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 1), which contains the Cochrane Acute Respiratory Infections (ARI) Group's Specialised Register, MEDLINE (1966 to February 2011), EMBASE (1974 to February 2011) and LILACS (1982 to February 2011). We also performed an electronic search of meeting proceedings from the American Association of Neurological Surgeons (1997 to September 2005) and handsearched the abstracts of meeting proceedings of the European Association of Neurosurgical Societies (1995, 1999 and 2003). Randomised controlled trials (RCTs) comparing any antibiotic versus placebo or no intervention. We also identified non‐RCTs to perform a separate meta‐analysis to compare results. At least two authors independently appraised trial quality and extracted data for each trial. We identified five RCTs and 17 non‐RCTs comparing different types of antibiotic prophylaxis with placebo or no intervention in patients with BSF. Most trials presented insufficient methodological detail. All studies included meningitis in their primary outcome. Overall, we evaluated 208 participants from the five RCTs that were considered suitable for inclusion in the meta‐analysis. There were no significant differences between antibiotic prophylaxis groups and control groups in terms of reduction of the frequency of meningitis, all‐cause mortality, meningitis‐related mortality, and need for surgical correction in patients with CSF leakage. There were no reported adverse effects of antibiotic administration, although one of the five RCTs reported an induced change in the posterior nasopharyngeal flora towards potentially more pathogenic organisms resistant to the antibiotic regimen used in prophylaxis. We performed a subgroup analysis to evaluate the primary outcome in patients with and without CSF leakage. We also completed a meta‐analysis of all the identified controlled non‐RCTs (enrolling a total of 2168 patients), producing results consistent with the randomised data. Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with BSF, whether there is evidence of CSF leakage or not. Until more research is completed, the effectiveness of antibiotics in patients with BSF cannot be determined because studies published to date are flawed by biases. Large, appropriately designed RCTs are needed. Antibioprophylaxie pour prévenir la méningite chez les patients souffrant de fractures de la base du crâne Les fractures de la base du crâne rendent les patients plus vulnérables à la méningite du fait de la possibilité de contact direct entre le système nerveux central (SNC) et les bactéries présentes dans les sinus paranasaux, le nasopharynx ou l'oreille moyenne. La perte de liquide céphalo‐rachidien (LCR) a été associée à un risque plus élevé de contracter une méningite. Les antibiotiques sont souvent administrés à titre prophylactique, bien que leur rôle dans la prévention de la méningite bactérienne ne soit pas établi. Évaluer l'efficacité des antibiotiques prophylactiques dans la prévention de la méningite chez les patients souffrant de fractures de la base du crâne. Nous avons effectué des recherches dans le registre Cochrane des essais contrôlés (CENTRAL) (Bibliothèque Cochrane 2011, numéro 1) qui contient le registre spécialisé du groupe Cochrane sur les infections respiratoires aiguës (IRA), ainsi que dans MEDLINE (1966 à février 2011), EMBASE (1974 à février 2011) et LILACS (1982 à février 2011). Nous avons également procédé à des recherches électroniques des actes de conférence de l'Association of Neurological Surgeons (1997 à septembre 2005) et à des recherches manuelles des résumés d'actes de conférence de l'European Association of Neurosurgical Societies (1995, 1999 et 2003). Les essais contrôlés randomisés (ECR) comparant tout antibiotique à un placebo ou à l'absence d'intervention. Nous avons également identifié des essais contrôlés non randomisés pour effectuer une méta‐analyse distincte visant à comparer les résultats. Au moins deux auteurs de revue ont, de manière indépendante, évalué la qualité et extrait les données de chaque essai. Nous avons identifié cinq ECR et dix‐sept essais contrôlés non randomisés comparant différents types d'antibioprophylaxie à un placebo ou à l'absence d'intervention chez des patients souffrant de fractures de la base du crâne. La majorité des essais présentaient trop peu de détails méthodologiques. Le critère de jugement principal de toutes les études était la méningite. Globalement, nous avons évalué 208 participants à partir de cinq ECR considérés comme adaptés pour être inclus dans la méta‐analyse. Aucune différence significative n'était observée entre les groupes d'antibioprophylaxie et les groupes témoins en termes de réduction de la fréquence de la méningite, de mortalité toutes causes confondues, de mortalité liée à la méningite et de nécessité d'une correction chirurgicale chez les patients présentant une perte du LCR. Aucun effet indésirable dû à l'administration d'antibiotiques n'était signalé, mais l'un des cinq ECR rapportait un changement induit dans la flore naso‐pharyngée postérieure se traduisant par un plus grand nombre d'agents pathogènes potentiellement résistants au régime antibiotique utilisé dans la prophylaxie. Une analyse en sous groupe a été effectuée afin d'évaluer le critère de jugement principal chez les patients connaissant ou non une perte du LCR. Nous avons aussi réalisé une méta‐analyse de tous les essais contrôlés non randomisés identifiés (comprenant un total de 2168 patients), produisant ainsi des résultats cohérents avec les données randomisées. À l'heure actuelle, les preuves disponibles provenant d'ECR ne sont pas favorables à l'utilisation d'antibiotiques prophylactiques chez les patients souffrant de fractures de la base du crâne, qu'ils présentent ou non des signes de perte du LCR. Tant que d'autres recherches ne sont pas réalisées, il ne sera pas possible de déterminer l'efficacité des antibiotiques chez les patients souffrant de fractures de la base du crâne, car les études menées jusqu'à présent sont entachées de biais. Des ECR réalisés à grande échelle et correctement planifiés sont nécessaires.


  • Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review

    by Bernardo Ratilal, João Costa, Cristina Sampaio

    Object: Systemic antibiotics and antibiotic-impregnated shunt (AIS) systems are often used to prevent shunt infection. The authors conducted a systematic review to evaluate its effectiveness of antibiotics in patients who underwent placement of intracranial ventricular shunts. Methods: The authors searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, LILACS, and the meeting proceedings from the American Association of Neurological Surgeons and from the European Association of Neurosurgical Societies until June 2005. Randomized and quasi-randomized trials comparing the use of prophylactic antibiotics (either systemic or AIS systems) in intracranial ventricular shunt procedures with placebo or no antibiotics were included in the review. Results: Seventeen trials involving 2134 patients were included. Results from the metaanalysis showed that the use of systemic antibiotic prophylaxis for internal shunts was associated with a decrease in shunt infection (odds ratio 0.51; 95% confidence interval 0.36–0.73). The authors found no significant differences between the subgroups evaluated in type of internal shunt (ventriculoperitoneal/ventriculoatrial), age, or duration of the administration of antibiotics. Conclusions: The authors found a benefit of systemic prophylactic antibiotics in preventing shunt infection, regardless of the patient's age and the type of internal shunt used. The benefit of its use after the first 24 hours postoperatively remains uncertain. Future trials should be conducted to evaluate the effectiveness of different regimens of systemic antibiotics rather than placebo, namely single preoperative dose versus multiple doses. It should also be mandatory to evaluate the effectiveness of systemic prophylactic antibiotics for external ventricular drains. Evidence suggests that antibiotic-impregnated catheters reduce the incidence of shunt infection, although more well-designed clinical trials are needed.


  • Traumatic clivus epidural hematoma: case report and review of the literature

    by Bernardo Ratilal, Pedro Castanho, Carlos Vara Luiz, João Oliveira Antunes


  • Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts

    by B Ratilal, J Costa, C Sampaio

    Systemic antibiotics and antibiotic-impregnated shunt systems are often used to prevent shunt infection. To evaluate the effectiveness of either prophylactic systemic antibiotics or antibiotic-impregnated shunt systems for preventing infection in patients who underwent surgical introduction of intracranial ventricular shunts. We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, LILACS and the meeting proceedings from the American Association of Neurological Surgeons and from the European Association of Neurosurgical Societies, until June 2005. We included randomized or quasi-randomized controlled trials comparing the use of prophylactic antibiotics (either systemic or antibiotic-impregnated shunt systems) in intracranial ventricular shunt procedures with placebo or no antibiotics. Two authors appraised quality and extracted data independently. We included seventeen trials with overall 2134 participants. We performed two separate meta-analyses: one that evaluated the use of systemic prophylactic antibiotics and another that evaluated the use of antibiotic-impregnated systems. All studies included shunt infection in their primary outcome. We could not analyse all-cause mortality regarding systemic antibiotics due to lack of data. No significant differences were found (odds ratio (OR): 1.47, 95% confidence intervals (CI) 0.83 to 2.62) for this outcome regarding the use of antibiotic-impregnated catheters compared with standard ones. The use of systemic antibiotic prophylaxis and the use of antibiotic-impregnated catheters were associated with a decrease in shunt infection (OR: 0.52, 95% CI 0.36 to 0.74 and OR: 0.21, 95% CI 0.08 to 0.55 respectively). We found no significant benefit for shunt revision in both meta-analyses that evaluated systemic antibiotics and impregnated-shunt systems. We found no significant differences between the subgroups evaluated: type of shunt (internal/external, ventriculoperitoneal/ventriculoatrial), age and duration of the administration of antibiotics. We could demonstrate a benefit of systemic prophylactic antibiotics for the first 24 hours postoperatively to prevent shunt infection, regardless of the patient's age and the type of internal shunt used. The benefit of its use after this period remains uncertain. However this data derives from the rate of shunt infection, which is an intermediary outcome. Future trials should evaluate the effectiveness of different regimens of systemic antibiotics rather than placebo, and should include all-cause mortality, shunt revision and adverse events as additional outcomes. Evidence suggests that antibiotic-impregnated catheters reduce the incidence of shunt infection although more well-designed clinical trials testing the effect of antibiotic-impregnated shunts are required to confirm their net benefit.


  • Aggressive intracranial and extra‐cranial epithelioid hemangioendothelioma: A case report and review of the literature

    by Antonio L. Fernandes, Bernardo Ratilal, Manuela Mafra, Coriolano Magalhaes

    Epithelioid hemangioendothelioma is a rare tumor of intermediate malignancy. Twelve intracranial cases have been well documented. We report an intra‐ and extra‐cranial single mass epithelioid hemangioendothelioma. We describe the case of a 27‐year‐old male who presented a left temporal and retroauricular pain and an intra and extra‐cranial mass extending to the left infratemporal fossa. The neoplasm was isointense with gray matter in both T1 and T2‐weighted images, showing marked nodular gadolinium enhancement. About 90% of the tumor was surgically removed. The neoplasm was fibrous, well defined and arose from the left temporal artery branches. Recovery was uneventful. The histological diagnosis was epithelioid hemangioendothelioma. Enhanced magnetic resonance scan was repeated at 3 and 6 months after surgery, showing an increasing mass volume extending to the surrounding tissues, including intracranially, infratemporal fossa and left orbit. The patient died 8 months after the initial diagnosis. Epithelioid hemangioendotheliomas can be very aggressive tumors, presenting initially at an intra‐ and extra‐cranial location, due to its fast growth. From our review of the literature, they seem to have an equal gender distribution (M : F = 7 : 6) and tend to affect people under the age of 30 (10/13). We report a unique and extremely aggressive tumor. The rarity of reports and the continuous spectrum of differentiation, ranging from borderline to highly malignant are obstacles to identifying initial therapeutic protocols and the adjunctive therapy after surgery.


  • Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures

    by Bernardo O Ratilal, João Costa, Cristina Sampaio

    Basilar skull fractures (BSF) predispose patients to meningitis because of the possible direct contact of bacteria in the paranasal sinuses, nasopharynx or middle ear with the central nervous system (CNS). Cerebrospinal fluid (CSF) leakage has been associated with a greater risk of contracting meningitis. Antibiotics are often given prophylactically, although their role for preventing bacterial meningitis is not established. To evaluate the effectiveness of prophylactic antibiotics for preventing meningitis in patients with BSF. We searched the Cochrane Register of Controlled Trials (CENTRAL) (The Cochrane Library 2005, issue 3) which contains the Acute Respiratory Infections (ARI) Group's Specialized Regsiter, MEDLINE (1966 to September 2005), EMBASE (1974 to June 2005), and LILACS (1982 to September 2005). We also performed an electronic search of meeting proceedings from the American Association of Neurological Surgeons (1997 to September 2005) and handsearched the abstracts of meeting proceedings of the European Association of Neurosurgical Societies (1995, 1999 and 2003). Randomised controlled trials (RCTs) comparing any antibiotic versus placebo or no intervention. We also identified non‐RCTs to perform a separate meta‐analysis to compare results. At least two authors independently appraised the quality and extracted the data of each trial. Five RCTs and 17 non‐RCTs comparing different types of antibiotic prophylaxis with placebo or no intervention in patients with BSF were identified. Most trials presented insufficient methodological detail. All studies included meningitis in their primary outcome. Overall, we evaluated 208 participants from the four RCTs that were considered suitable for inclusion in the meta‐analysis. There were no significant differences between antibiotic prophylaxis groups and control groups in terms of reduction of the frequency of meningitis, all‐cause mortality, meningitis‐related mortality, and need for surgical correction in patients with CSF leakage. We performed a subgroup analysis to evaluate the primary outcome in patients with and without CSF leakage. We also completed a meta‐analysis of all the identified controlled non‐RCTs (enrolling a total of 2168 patients), producing results consistent with the randomised data. Currently available evidence from RCTs does not support prophylactic antibiotic use in patients with BSF, whether there is evidence of CSF leakage or not. Until more research is completed, the effectiveness of antibiotics in patients with BSF cannot be determined because studies published to date are flawed by biases. Large, appropriately designed RCTs are needed.